These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26238225)

  • 21. A pilot open-label trial of citalopram for restless activity and aberrant motor behaviors in Alzheimer disease.
    Scharre DW; Davis RA; Warner JL; Chang SI; Beversdorf DQ
    Am J Geriatr Psychiatry; 2003; 11(6):687-91. PubMed ID: 14609811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.
    Choe YM; Kim KW; Jhoo JH; Ryu SH; Seo EH; Sohn BK; Byun MS; Bak JH; Lee JM; Yun HJ; Han MI; Woo JI; Lee DY
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):731-9. PubMed ID: 26553313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.
    Wang LY; Shofer JB; Rohde K; Hart KL; Hoff DJ; McFall YH; Raskind MA; Peskind ER
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):744-51. PubMed ID: 19700947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancements in the treatment of agitation in Alzheimer's disease.
    Antonsdottir IM; Smith J; Keltz M; Porsteinsson AP
    Expert Opin Pharmacother; 2015; 16(11):1649-56. PubMed ID: 26159445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating dementia and agitation.
    Small GW
    JAMA; 2014 Feb; 311(7):677-8. PubMed ID: 24549545
    [No Abstract]   [Full Text] [Related]  

  • 26. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
    Grossberg GT; Kohegyi E; Mergel V; Josiassen MK; Meulien D; Hobart M; Slomkowski M; Baker RA; McQuade RD; Cummings JL
    Am J Geriatr Psychiatry; 2020 Apr; 28(4):383-400. PubMed ID: 31708380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
    Tariot PN; Raman R; Jakimovich L; Schneider L; Porsteinsson A; Thomas R; Mintzer J; Brenner R; Schafer K; Thal L; ;
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):942-9. PubMed ID: 16286437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.
    Devanand DP; Pelton GH; Cunqueiro K; Sackeim HA; Marder K
    Int J Geriatr Psychiatry; 2011 Sep; 26(9):937-43. PubMed ID: 21845596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
    Herrmann N; Ruthirakuhan M; Gallagher D; Verhoeff NPLG; Kiss A; Black SE; Lanctôt KL
    Am J Geriatr Psychiatry; 2019 Nov; 27(11):1161-1173. PubMed ID: 31182351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial.
    Devanand DP; Crocco E; Forester BP; Husain MM; Lee S; Vahia IV; Andrews H; Simon-Pearson L; Imran N; Luca L; Huey ED; Deliyannides DA; Pelton GH
    Am J Geriatr Psychiatry; 2022 Jan; 30(1):32-42. PubMed ID: 34059401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citalopram for verbal agitation in patients with dementia.
    Kim KY; Bader GM; Jones E
    J Geriatr Psychiatry Neurol; 2000; 13(2):53-5. PubMed ID: 10912724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram.
    Herrmann N
    Evid Based Ment Health; 2016 Nov; 19(4):e24. PubMed ID: 27613071
    [No Abstract]   [Full Text] [Related]  

  • 37. Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study.
    De Mauleon A; Delrieu J; Cantet C; Vellas B; Andrieu S; Rosenberg PB; Lyketsos CG; Soto Martin M
    J Prev Alzheimers Dis; 2021; 8(2):199-209. PubMed ID: 33569568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: a placebo-controlled study.
    Peskind ER; Tsuang DW; Bonner LT; Pascualy M; Riekse RG; Snowden MB; Thomas R; Raskind MA
    Alzheimer Dis Assoc Disord; 2005; 19(1):23-8. PubMed ID: 15764868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
    Wilcock GK; Ballard CG; Cooper JA; Loft H
    J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania.
    Stein DJ; Bouwer C; Maud CM
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(4):234-6. PubMed ID: 9332906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.